Lixte Biotechnology Holdings Files 8-K
Ticker: LIXT · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1335105
Sentiment: neutral
Topics: 8-K, filing, corporate-update
Related Tickers: LIXT
TL;DR
Lixte Biotech filed an 8-K on 3/27/25, check for updates.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on March 27, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Pasadena, California, previously operated under the name SRKP 7 INC. The filing does not disclose specific financial figures or material events beyond the reporting of these items.
Why It Matters
This filing indicates Lixte Biotechnology Holdings, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting other events and financial statements without specific material disclosures that would immediately impact risk.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer
- SRKP 7 INC (company) — Former company name
- March 27, 2025 (date) — Date of report
FAQ
What specific 'Other Events' are being reported by Lixte Biotechnology Holdings, Inc. in this 8-K filing?
The filing indicates 'Other Events' are being reported, but the specific details of these events are not provided in the provided text.
What is the significance of filing 'Financial Statements and Exhibits' in this 8-K?
Filing 'Financial Statements and Exhibits' suggests the company is providing updated financial information or accompanying documents as required by the SEC.
When was Lixte Biotechnology Holdings, Inc. previously known as SRKP 7 INC?
The company changed its name from SRKP 7 INC on August 3, 2005.
Where are Lixte Biotechnology Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
What is the SEC file number for Lixte Biotechnology Holdings, Inc.?
The SEC file number for Lixte Biotechnology Holdings, Inc. is 001-39717.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).